Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tokomeza Ebola ring vaccination trial for Sudan ebolavirus vaccine in Uganda
PACTR202502515126090Phase 3Recruiting
- Sponsor
- Ministry of Health of Uganda
- Start
- Feb 2025
- Modality
- Live Vector Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Sudan ebolavirus vaccine in Sudan ebolavirus disease (SVD) and Ebola virus disease (EVD) (2 arms), sponsored by Ministry of Health of Uganda. Primary endpoint: Laboratory-confirmed Sudan ebolavirus disease. Started Feb 2025; status: recruiting.
02
Drugs
Sudan ebolavirus vaccine
03
Conditions
Sudan ebolavirus disease (SVD)Ebola virus disease (EVD)
Beyond the preview
Go deeper on PACTR202502515126090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202502515126090.